| 產品名稱 |
MMA |
| 商品貨號 |
B165175 |
| Organism |
Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type |
hybridoma: B lymphocyte |
| Product Format |
frozen |
| Morphology |
lymphoblast |
| Culture Properties |
suspension |
| Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Applications |
The antibody reacts with human adherent mononuclear cells and granulocytes. Tested and found negative for ectromelia virus (mousepox). |
| Derivation |
Spleen cells were fused with P3X63Ag8.653 myeloma cells. |
| Genes Expressed |
immunoglobulin; monoclonal antibody; against human monocyte |
| Cellular Products |
immunoglobulin; monoclonal antibody; against human monocyte |
| Comments |
Animals were immunized with the U-937 histiocytic cell line (ATCC CRL-1593). Spleen cells were fused with P3X63Ag8.653 myeloma cells. The antibody reacts with human adherent mononuclear cells and granulocytes. The antibody does not react with circulating T cells, B cells, erythrocytes or platelets. The antibody is cytotoxic. Tested and found negative for ectromelia virus (mousepox). |
| Complete Growth Medium |
The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype |
IgM; kappa light chain |
| Name of Depositor |
JF Kearney, H Kubagawa |
| Deposited As |
mouse (B cell); mouse (myeloma) |
| References |
Hanjan SN, et al. A monoclonal antibody (MMA) that identifies a differentiation antigen on human myelomonocytic cells. Clin. Immunol. Immunopathol. 23: 172-188, 1982. PubMed: 6179666
|
